january 27th, 2011
Happy Holidays, here is a Bonus Pick for you!
(Cash Covers Puts, this is not a naked Option.) IDCC @ $40.70
Sell to Open, IDCC December 2011 $34.00 Put @ $1.15
Limit, Good until Cancelled (3.38% Gain in 18 days) $10,000.00 would generate $338.00
income in 18 days
How to do this trade Video: http://www.youtube.com/watch?v=GaqgP-H2snc
Interdigital, Inc (IDCC). engages in the design and development of digital wireless
technology solutions. The company offers technology solutions for use in digital cellular
and wireless products and networks, including 2G, 3G, 4G, and IEEE 802-related
products and networks. It holds patents related to the fundamental technologies that
enable wireless communications. The company licenses its patents to equipment
producers that manufacture, use, and sell digital cellular and IEEE 802-related products;
and licenses or sells mobile broadband modem solutions, including modem IP, know-how,a
nd reference platforms to mobile device manufacturers, semiconductor companies, and
other equipment producers that manufacture, use, and sell digital cellular products.
InterDigitalolutions are incorporated in various products comprising mobile devices,
such as cellular phones, tablets, notebook computers, and wireless personal digital
assistants; wireless infrastructure equipment, such as base stations; and components,
dongles, and modules for wireless devices. The company was founded in 1972 and is he
adquartered in King of Prussia, Pennsylvania.
Modify an Open Order TRGT @ $6.80
Sell to Open TRGT February 2012 $15.00 Call @ $.40c
Limit, Good until Canceled
(+3.2% Gain in 19 Days)
How to do this trade Video: http://www.youtube.com/watch?v=3lYlUhMR4o8
Cost basis $12.50 per share.
Premiums collected: $1.60
per share 12.8% Return in 1 months $10,000 would have generated $1280.00 11/18/2011 Buy To Close TRGT Nov11 12.5 Put 11/18/2011 Buy TRGT–
Option Assignment $12.50
10/23/2011 Sell to
Open TRGT Nov 11 $12.50 PUT @$1.60 Limit (12.8% gain)
Targacept, Inc., a biopharmaceutical company, engages in the design, discovery, and
development of novel Neuronal Nicotinic Receptors (NNR) Therapeutics for the treatment
of diseases and disorders o
f the nervous system. Its lead program, TC
5214, a nicotinic
channel modulator, is in Phase 3 clinical trials as an adjunct treatment for major
depressive disorder (MDD) and in Phase 2b clinical trial for switch monotherapy in
patients with MDD. The companyQuote of the Month:
“Wall Street is the only place that people ride to work in a Rolls
Royce to get advice from those who take the subway.“
Until Next Time
Brad Lee The Options Oracle
Greetings and Welcome aboard to
all new subscribers.
Congrats to all with successful trades.
review our definitions in order
to get acquainted with language we
will be using” https://theoptionsoracle.com/glossary
Feel free to look at our past issues
because many trades last multiple
Links to the actual trades is HERE Company News
Auto Trading is now active!
Don’t want to be bothered doing the
Auto-trading is for you. Your account
will automatically do whatever I do.
You are still in control, you set the
limits either a dollar amount or a
percentage.Go to the main site, the Auto-trade
link is on the right https://theoptionsoracle.com/
Disclosure: These are my actual
Your subscription fee may be
100% TAX DEDUCTIBLE if used for
Check with your Licensed.
recommendations are for educational
purposes, this is not intended as Trading or
We are not financial advisers. We cannot provide any advice as to
whether or not options or our trading ideas are
suitable investments for your particular
financial situation. Disclaimer
Trading or investment in stocks, futures &
options, and commodity are subject to potential
market risks. You can use our materials for
education and entertainment purposes only.
We are in the business of publishing our trade
ideas for market analysis only. We highly
recommend that our subscribers review their
trading allocation with a qualified
registered financial adviser/planner.
Legal Disclaimer: we do not exist to render and
do not give legal, tax, economic or investment
advice and disclaims all liability for the actions
or inaction taken or not as a result of
communications from or to its
members, officers, directors, employees and contractors.
Each individual should consult his/her own
counsel, accountant and other advisors as to
legal, tax, economic, investment and related
matters concerning any type of investments.
This email and any files transmitted with it are
solely intended for the use of the addressee(s)
and may contain information that is confidential
and privileged. If you receive this email in error,
please advise us by return email immediately.
Please also disregard the contents of the
email, delete it and destroy any copies
immediately.Options involve risk and are not suitable
for all investors. Prior to trading options,
you must be approved for options
trading and read the Characteristics
and Risks of Standardized Options.
Copies of this document may also be obtained from your broker, from any
exchange on which options are traded, by
placing an order online, or by contacting
the Options Clearing Corporation directly
at 1 N. Wacker Dr., Suite 500, Chicago, IL60606. (1-888-678-4667).
Brad Lee AKA “The Options Oracle”
and “The Money Medic” is an
individual investor who does not
manage money for any financial
institution.You are purchasing the list
of stocks that he uses to select
options contracts he feels will return
him the highest, safest profits. Brad is
not a broker, or financial adviser. He
is a remarkable investor who has
developed a successful strategy for
himself, and is willing to share some of his magic with you. We urge you
to paper trade these picks and learn
how to develop a strategy that is
appropriate for you.Thank You.
We make no recommendations on
investment and we do not provide
financial, tax or legal advice. Content
and tools are provided for educational
and informational purposes only.